BIO GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Bio-Rad Laboratories Inc - Class A
Exchange: NYSESector: HealthcareIndustry: Medical Devices
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives.
Did you know?
Earnings per share grew at a -13.1% CAGR.
Current Price
$292.23
+1.41%GoodMoat Value
$938.27
221.1% undervaluedProfile
Valuation (TTM)
Market Cap$7.88B
P/E10.37
EV$6.99B
P/B1.06
Shares Out26.97M
P/Sales3.05
Revenue$2.58B
EV/EBITDA7.40
Bio-Rad Laboratories Inc - Class A (BIO) Quality Analysis
BIO Profitability
Profitability trend analysis coming soon
BIO Growth
Growth trend analysis coming soon
BIO Financial Health
Financial health indicators coming soon
BIO Quality & Fundamental Analysis
Bio-Rad Laboratories Inc - Class A (BIO) is a Healthcare company in the Medical Devices industry, listed on NYSE. This quality analysis page evaluates Bio-Rad Laboratories Inc - Class A's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Bio-Rad Laboratories Inc - Class A has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 29.42% and a return on equity (ROE) of 10.20%. Return on assets (ROA) stands at 7.18%.
The debt-to-equity ratio is 0.19, with a current ratio of 5.62. Operating margin is 1.83%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Bio-Rad Laboratories Inc - Class A is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.